Literature DB >> 6337294

Iatrogenic, insulin-dependent, local amyloidosis.

S Störkel, H M Schneider, H Müntefering, S Kashiwagi.   

Abstract

Human and experimental amyloidosis can occur either as a generalized widespread deposit of various proteins or a localized deposit. We looked for local amyloidosis caused iatrogenically under clinical and experimental conditions. Subcutaneous tissue from one diabetic patient and six Wistar rats, which had received a continuous local infusion of 1.2 iu of insulin daily for 6 weeks, was examined histologically. In all cases the development of granulation tissue around the tip of the catheter was observed. In addition, inhomogenous extracellular deposits showing green birefringence under polarized light when stained Congo red were seen. Immunohistologically, they displayed binding of anti-insulin antibody. Electron microscopy demonstrated a typical spear-like fibrillar structure with a fibril diameter of 60 to 80 A. These findings confirmed that the deposited substance was amyloid. Iatrogenically administered protein produced in vivo amyloidosis at the site of its entry. Insulin can lead to the formation of amyloid fibrils not only in vitro but also in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337294

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  18 in total

1.  Molecular basis for insulin fibril assembly.

Authors:  Magdalena I Ivanova; Stuart A Sievers; Michael R Sawaya; Joseph S Wall; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

2.  Normal and reversed supramolecular chirality of insulin fibrils probed by vibrational circular dichroism at the protofilament level of fibril structure.

Authors:  Dmitry Kurouski; Rina K Dukor; Xuefang Lu; Laurence A Nafie; Igor K Lednev
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

3.  Elucidating the locking mechanism of peptides onto growing amyloid fibrils through transition path sampling.

Authors:  Marieke Schor; Jocelyne Vreede; Peter G Bolhuis
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

4.  Controlling the aggregation and rate of release in order to improve insulin formulation: molecular dynamics study of full-length insulin amyloid oligomer models.

Authors:  Workalemahu Mikre Berhanu; Artëm E Masunov
Journal:  J Mol Model       Date:  2011-06-15       Impact factor: 1.810

5.  Spontaneous inter-conversion of insulin fibril chirality.

Authors:  Dmitry Kurouski; Rina K Dukor; Xuefang Lu; Laurence A Nafie; Igor K Lednev
Journal:  Chem Commun (Camb)       Date:  2012-01-12       Impact factor: 6.222

6.  Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration.

Authors:  Anita D'Souza; Jason D Theis; Julie A Vrana; Ahmet Dogan
Journal:  Amyloid       Date:  2014-01-22       Impact factor: 7.141

7.  Imaging characteristics of subcutaneous amyloid deposits in diabetic patients: the "insulin ball".

Authors:  Noriko Tanio; Taiki Nozaki; Masaki Matsusako; Jay Starkey; Koyu Suzuki
Journal:  Skeletal Radiol       Date:  2017-08-28       Impact factor: 2.199

8.  Modulating Insulin Fibrillation Using Engineered B-Chains with Mutated C-Termini.

Authors:  Mohsen Akbarian; Reza Yousefi; Ali Akbar Moosavi-Movahedi; Atta Ahmad; Vladimir N Uversky
Journal:  Biophys J       Date:  2019-09-23       Impact factor: 4.033

9.  Double-layer mediated electromechanical response of amyloid fibrils in liquid environment.

Authors:  M P Nikiforov; G L Thompson; V V Reukov; S Jesse; S Guo; B J Rodriguez; K Seal; A A Vertegel; S V Kalinin
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

10.  Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient.

Authors:  F E Dische; C Wernstedt; G T Westermark; P Westermark; M B Pepys; J A Rennie; S G Gilbey; P J Watkins
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.